1.Peripheral T cell lymphoma and nature killer cell iymphoma
Journal of International Oncology 2011;38(12):940-942
Peripheral T cells are closely related to nature killer( NK)cells,and share some immunophenotypic and functional properties with NK cells.Peripheral T-cell and NK cell lymphomas are heterogeneous groups of lymphomas,and the subgroup classification is complicated.Currently,the pathogenetic molecular lesions remain not to be deciphered for most entities.However,novel insights into the features of angioimmunoblastic T-cell lymphoma displaying correlation with normal helper T cells,the gene of anaplastic large cell lymphoma,and potential therapeutic biomarkers,have been gained from molecular technology application.
2.Differential diagnosis of lung cancer in patients with a history of breast cancer
Journal of International Oncology 2011;38(5):367-370
A differential diagnosis between primary and metastatic cancers is required in lung cancer patients with a history of breast cancer, However, the limited morphological findings are not enough to differentiate many atypical cases. Essential immunohistochemical and molecular markers are helpful for differential diagnosis. Combined markers currently specific and sensitive to lung or breast carcinomas can improve the efficacy of differential diagnosis between primary lung cancers and metastatic breast cancers.
3.Glomus tumor of the trachea.
Chinese Journal of Pathology 2005;34(2):124-125
Actins
;
metabolism
;
Adult
;
Glomus Tumor
;
metabolism
;
pathology
;
surgery
;
Humans
;
Male
;
Trachea
;
pathology
;
Tracheal Neoplasms
;
metabolism
;
pathology
;
surgery
;
Tracheotomy
;
Vimentin
;
metabolism
4.Case of adhesive ileus.
Chinese Acupuncture & Moxibustion 2013;33(10):930-930
Acupuncture Therapy
;
Defecation
;
Female
;
Humans
;
Ileus
;
physiopathology
;
therapy
;
Middle Aged
5.Morphologic change of metastatic renal cell carcinoma treated with sorafenib:report of 2 cases
Shan ZHENG ; Jianhui MA ; Ning Lü ; Yanling YUAN ; Xiuyun LIU
Chinese Journal of Urology 2009;30(1):36-39
Objective To investigate the characters of morphology change and protein expres-sion in progressed renal cell carcinoma after the treatment of sorafinib. Methods Clinical data of 2 cases with progressed renal cell carcinoma treated with sorafenib were collected. The HE slices were reviewed. Immunochemistry was used to detect the expression of Vimentin, AE1/AE3, CK7, CK8, CK18, CD10, VEGF, VEGFR2, p53 and Ki-67 levels. Results There was no difference in patho-logic type between before and after the therapy of sorafenib. Both of the 2 cases were showed degener-ation in tumor cell in different degree with fibrosis and necrosis. The expression of renal cell carcinoma related antigens (Vimentin, AE1/AE3, CK7, CK8, CK18 and CD10) had no difference before and af-ter the treatment of sorafinib. The expressions of VEGF, VEGFR2, p53 and Ki-67 were increased, and the expression of Bcl-2 was decreased after the therapy of sorafinib. Conclusions There may be some morphologie differences between the metastatic tumor or the recurrent tumor and primary tumor because of the treatment of sorafenib. However the pathologic type is the same before and after the treatment of sorafenib. The main differences are the degeneration of the tumor cell and fibrosis after the treatment of sorafenib. The expression changes of VEGF and VEGFR2 may be related to the sor-afenib application.
6.Prognostic risk factors for surgery in patients with cirrhotic portal hypertension
Yunfu Lü ; Ning LIU ; Shijie ZHANG ; Yongbin PANG ; Jie YUE
Chinese Journal of Hepatobiliary Surgery 2012;18(4):278-282
Objective To investigate the prognostic risk factors for surgery in patients with cirrhotic portal hypertension.Methods One hundred and sixty one patients with cirrhotic portal hypertension who received surgery in our hospital in the past 10 years were studied.The data were entered into a pre-designed form.24 predictors including patients′ age,sex,degree of liver atrophy,ChildPugh classification,coagulation profile,splenic size,renal function,blood pH,base excess (BE),operative time,volume of ascites,and intraoperative and postoperative hemorrhage were recorded and analyzed.For each of the predictors,2-3 subgroups were compared.Results Seven predictors were clearly related to surgical prognosis:postoperative bleeding within 30h (B0.356,P<0.001) and a bleeding volume >2 L were awarded 3 points; liver volume (B-0.160,P<0.001) and severe liver atrophy (antero-posterior diameter of the left liver lobe ≤55 mm,oblique diameter of the right lobe ≤110 mm) were awarded three points; blood pH (B0.141,P<0.001),pH<7.35 was awarded 2 points; BE (B-0.123,P<0.001),BE<-3 (mmol/L) was awarded 2 points; decrease in PLT (B0.065,P =0.015),PLT< 3 (T/L) was awarded 2 points; intraoperative bleeding (B0.062,P=0.014),bleeding volume >2 L was awarded 2 points; decrease in RBC (B0.053,P=0.024),<3(G/L) was awarded 1 point.Of the 147 patients who recovered from surgery,all had ≤3 points,except one who had 4 points.Of the 14 patients who died,all had ≥5 points except one who had 4 points.Conclusions Postoperative bleeding (>2 L),severe liver atrophy (antero-posterior diameter of the left live lobe ≤55 mm,oblique diameter of the right lobe ≤110 mm),blood PH<7.35,BE <-3 (mmol/L),PLT<30 000(T/L),intraoperative major bleeding (>2 L) and RBC<3 (G/L) were significant prognostic risk factors for surgery.For patients who had a score of 5-6 points; death was likely following surgery.A score ≥8 points should be considered as a contraindication to surgery.To reduce operative mortality,active treatment should be given before surgery to keep the score to be 4 points or less.
7.Etiology and classification of cholangiectasia: an analysis of 1098 cases
Baochun WANG ; Yunfu Lü ; Xiaoyu HAN ; Ning LIU ; Jie YUE
Chinese Journal of Hepatobiliary Surgery 2011;17(9):752-754
ObjectiveTo review the etiology and classification of cholangiectasia. MethodThe clinical data of 1098 patients with cholangiectasia treated from January 2000 to December 2009 were retrospectively analyzed. Results For the 1098 patients, 69 patients (6.3%) had congenital choledochal cyst, and 1029 patients (93.7%) had secondary cholangiectasia which were secondary to 22 diseases, The top 5 of the etiological diseases were bile duct stones (366 patients, 33.3 %), pancreatic head carcinoma (137 patients, 12.5%), peri-ampullary carcinoma (122 patients, 11.1%), cholangiocarcinoma (68 patients,6.2%),and chronic pancreatitis or pancreatic head cyst (62 patients,5.6 %). ConclusionsCholangiectasia can be divided into two major categories (congenital and secondary). Congenital choledochal cyst accounted for 6.0%, secondary cholangiectasia accounted for 94 %.The most common etiologies were bile duct stones, pancreatic head carcinoma and peri-ampullar carcinoma.
8.p73 activation is involved in regulation of Ara-C-induced apoptosis in human lung adenocarcinoma cells
Lu ZHANG ; Ning LIU ; Danyü Lü ; Wanyun MA ; Ying LI
Acta Anatomica Sinica 2011;42(1):50-53
Objective To study the apoptosis pathway of human lung adenocarcinoma cell line A549 induced by 1-β-D-arabinofuranosylcytosine (Ara-C) in vitro. Methods A549 cells were incubated with Ara-C for 72hours in vitro. Biological changes of apoptotic cells were studied by TUNEL staining. Morphological changes of the A549 cells treated with Ara-C were observed by transmission electron microscope. The expressions of p53 and p73 were investigated by Western blotting. Results 1.Apoptotic rates of A549 cells exposure to Ara-C studied by TUNEL staining were higher than that of the control (P<0.01). 2.Apoptosis body was apparently observed by transmission electron microscope. 3.Endogenous p73 but not p53 was induced and activated in dose-dependent manner upon Ara-C treatment by Western blotting.Conclusion Ara-C can effectively induce apoptosis of A549 cells. DNA damage-induced apoptosis of A549 cells treated by Ara-C is independent of functional p53.Up-regulation of p73 may play an important role that enhances the sensitivity of A549 cells to Ara-C and be partly responsible for p53-independent apoptosis.
9.Study of arginine in combination with leptin in treatment of pancreatitis
Baoyong Lü ; Jun YAN ; Ning LI ; Yefeng ZHANG
Clinical Medicine of China 2010;26(3):318-321
Objective To investigate the effects of arginine combined with leptin in treatment of rats with a-cute pancreatitis. Methods Sixty Wister rats were randomly divided into sham operation group (group A), acute pancreatitis group (group B),arginine group (group C),leptin group (group D),arginine plus leptin group (group E),with 12 rats in each group. Acute panereatitis model was developed by retrograde injection of 5% sodium tauro-cholate into cholangiopancreatography in rats. After 6 hours, medicine were given by intraperitoneal injection, ab-dominal aortic blood and pancreatic specimens were taken for measurement of tumor necrosis factor-α(TNF-α), ser-um amylase,nuclear factor-κB (NF-κB) activity of pancreatic tissue, and pathological damage score of pancreatic tissue. Results TNF-α,Amylase,NF-κB activity, pathologic scores were(1.206±0.446)μg/L, (1617.2±18.8) U/L,0.174±0.013,0.6±0. 2 in group A;(3.201±0.321) μg/L, (4643.8±303.4) U/L,0.397±0. 025,7.8±1.3 in group B;(1.845±0.404) μg/L,(3370.9±173.2)U/L,0.255±0.026,3.9±1.1 in group C;(1.996±0.374) μg/L, (3693.7±208.0)U/L,0.274±0.062,4.2±1.2 in group D;(1.440±0.287)μg/L, (2501.0±771.4)U/L,0.211±0.027,2.3±1.0 in group E. Compared with group A, the indicators were significantly in-creased in group B (P < 0.05). Compared with group B, these indicators were reduced in group C and D (P <0.05). There was no significant difference between group C and group D. These indicators in group E were signifi-cantly lower than those in group C and D (P < 0.05). NF-κB in pancreatic tissue were positively correlated with other indicators(P <0.01). Conclusions In treatment of acme pancreatitis in rats, arginine combined with leptin has idenditfied effect, and the effect of combination therapy is better than that of separate medicine.
10.Clinical observation of three-step modified shoulder joint mobilization for scapulohumeral periarthritis
Zhigang Lü ; Jun ZHU ; Weicheng HU ; Chunrui NING ; Jue HONG
Journal of Acupuncture and Tuina Science 2016;14(1):36-40
Objective:To observe the clinical efficacy of the three-step modified shoulder joint mobilization in treating scapulohumeral periarthritis (SP).Methods:Totally 80 subjects were recruited and divided into a treatment group and a control group by using the random number table, 40 in each group. The treatment group was intervened by the three-step modified shoulder joint mobilization; the control group was by oral administration of Celebrex. After successive 4-week treatment, the improvement of shoulder pain and motor function was observed.Results:The total effective rate was 87.5% in the treatment group versus 80.0% in the control group, and the difference was statistically significant (P<0.05).Conclusion:The three-step modified shoulder joint mobilization is easy-to-operate and effective in treating SP.